Tags

Type your tag names separated by a space and hit enter

Clinical manifestation and risk factors of children with cleft palate receiving repeated ventilating tube insertions for treatment of recurrent otitis media with effusion.
Acta Otolaryngol. 2012 Jul; 132(7):702-7.AO

Abstract

CONCLUSION

From this study, we suggest that male gender and complete type of cleft palate contribute to the recurrence of otitis media with effusion (OME) in the patients with cleft palate.

OBJECTIVES

It is well known that children with cleft palate have a high prevalence of OME due to anatomic dysfunction of the eustachian tube. Our goal was to determine clinical manifestations and risk factors for children with cleft palate who received additional ventilating tube insertions after initial tube insertion during palatoplasty.

METHODS

We retrospectively reviewed the medical and operation records of 213 patients who received ventilating tube insertion during palatoplasty from January 1993 to June 2006. The single-VT group (n = 140) included patients who had one ventilating tube insertion only, and the repeated-VT group (n = 73) included patients who received ventilating tube insertion repeatedly because of recurring chronic OME. We analyzed age, sex, types of cleft palate, preoperative tympanogram, characteristics of discharge during myringotomy, and duration of first ventilating tube in situ.

RESULTS

There were significant differences between the single- and repeated-VT groups in the rate of male patients (43.6 vs 72.6%), the rate of complete cleft palate (30.0 vs 61.6%) and incomplete cleft palate (61.4 vs 26.0%), the rate of preoperative type A tympanogram (30.0 vs 13.7%) and type B tympanogram (57.1 vs 75.3%), the proportion of discharge during myringotomy (72.1 vs 86.3%), and the mean indwelling period of the first ventilating tube (12.7 ± 9.6 vs 10.5 ± 6.5 months). In addition, sex and type of cleft palate were proved to affect the repetition of VT independently. However, when we performed multivariate analysis, only complete type of cleft palate and male gender showed significant differences between single- and repeated-VT groups.

Authors+Show Affiliations

Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22668076

Citation

Ahn, Joong Ho, et al. "Clinical Manifestation and Risk Factors of Children With Cleft Palate Receiving Repeated Ventilating Tube Insertions for Treatment of Recurrent Otitis Media With Effusion." Acta Oto-laryngologica, vol. 132, no. 7, 2012, pp. 702-7.
Ahn JH, Kang WS, Kim JH, et al. Clinical manifestation and risk factors of children with cleft palate receiving repeated ventilating tube insertions for treatment of recurrent otitis media with effusion. Acta Otolaryngol. 2012;132(7):702-7.
Ahn, J. H., Kang, W. S., Kim, J. H., Koh, K. S., & Yoon, T. H. (2012). Clinical manifestation and risk factors of children with cleft palate receiving repeated ventilating tube insertions for treatment of recurrent otitis media with effusion. Acta Oto-laryngologica, 132(7), 702-7. https://doi.org/10.3109/00016489.2011.652309
Ahn JH, et al. Clinical Manifestation and Risk Factors of Children With Cleft Palate Receiving Repeated Ventilating Tube Insertions for Treatment of Recurrent Otitis Media With Effusion. Acta Otolaryngol. 2012;132(7):702-7. PubMed PMID: 22668076.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical manifestation and risk factors of children with cleft palate receiving repeated ventilating tube insertions for treatment of recurrent otitis media with effusion. AU - Ahn,Joong Ho, AU - Kang,Woo Seok, AU - Kim,Ji Heui, AU - Koh,Kyung S, AU - Yoon,Tae Hyun, Y1 - 2012/06/05/ PY - 2012/6/7/entrez PY - 2012/6/7/pubmed PY - 2013/2/12/medline SP - 702 EP - 7 JF - Acta oto-laryngologica JO - Acta Otolaryngol VL - 132 IS - 7 N2 - CONCLUSION: From this study, we suggest that male gender and complete type of cleft palate contribute to the recurrence of otitis media with effusion (OME) in the patients with cleft palate. OBJECTIVES: It is well known that children with cleft palate have a high prevalence of OME due to anatomic dysfunction of the eustachian tube. Our goal was to determine clinical manifestations and risk factors for children with cleft palate who received additional ventilating tube insertions after initial tube insertion during palatoplasty. METHODS: We retrospectively reviewed the medical and operation records of 213 patients who received ventilating tube insertion during palatoplasty from January 1993 to June 2006. The single-VT group (n = 140) included patients who had one ventilating tube insertion only, and the repeated-VT group (n = 73) included patients who received ventilating tube insertion repeatedly because of recurring chronic OME. We analyzed age, sex, types of cleft palate, preoperative tympanogram, characteristics of discharge during myringotomy, and duration of first ventilating tube in situ. RESULTS: There were significant differences between the single- and repeated-VT groups in the rate of male patients (43.6 vs 72.6%), the rate of complete cleft palate (30.0 vs 61.6%) and incomplete cleft palate (61.4 vs 26.0%), the rate of preoperative type A tympanogram (30.0 vs 13.7%) and type B tympanogram (57.1 vs 75.3%), the proportion of discharge during myringotomy (72.1 vs 86.3%), and the mean indwelling period of the first ventilating tube (12.7 ± 9.6 vs 10.5 ± 6.5 months). In addition, sex and type of cleft palate were proved to affect the repetition of VT independently. However, when we performed multivariate analysis, only complete type of cleft palate and male gender showed significant differences between single- and repeated-VT groups. SN - 1651-2251 UR - https://www.unboundmedicine.com/medline/citation/22668076/Clinical_manifestation_and_risk_factors_of_children_with_cleft_palate_receiving_repeated_ventilating_tube_insertions_for_treatment_of_recurrent_otitis_media_with_effusion_ L2 - https://www.tandfonline.com/doi/full/10.3109/00016489.2011.652309 DB - PRIME DP - Unbound Medicine ER -